LON:CYBG VanEck Bionic Engineering UCITS ETF A Acc (CYBG) Share Price, News & Analysis GBX 15.51 +0.09 (+0.56%) As of 08/29/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsBuy This Stock About VanEck Bionic Engineering UCITS ETF A Acc Stock (LON:CYBG) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get CYBG alerts:Sign Up Key Stats Today's Range 15.51▼ 15.7750-Day Range 14.99▼ 15.7752-Week Range 13.68▼ 17.89VolumeN/AAverage Volume279 shsMarket Capitalization£222.50 millionP/E RatioN/ADividend Yield0.19%Price TargetN/AConsensus RatingN/A Company Overview CYBG PLC, through its subsidiaries, provides retail and business banking products and services to individuals and businesses under the Clydesdale Bank, Yorkshire Bank, B, and Virgin Money brands in the United Kingdom. It operates through SME Banking and Retail Banking segments. The SME Banking segment offers a range of banking products and services, including business current accounts; and secured and unsecured term loans, business overdrafts, and invoice and asset financing products and services. It also provides international trade services, such as import loans, export loans, documentary collections, currency guarantees, and letters of credit for securing trade; and current account facilities comprising debit cards, cheque books, regular statements, direct debits, and standing orders, as well as day to day and online banking services. This segment serves business customers in the small business, commercial, corporate, and structured finance markets. The Retail Banking segment offers personal current accounts, savings accounts, and term deposits; occupied mortgage loans and BTL loans, unsecured personal loans, and overdrafts, as well as credit card products; and insurance and investment products. The company was founded in 1838 and is based in Leeds, the United Kingdom. Read More Receive CYBG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Bionic Engineering UCITS ETF A Acc and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CYBG Stock News HeadlinesAxa Im Msci Em Mkts Eq Pab Ucits Etf A Share Price (AIQU.MI)November 4, 2024 | lse.co.ukVanEck UCITS ETFs Plc - Notice Convening an Extraordinary General Meeting of ShareholdersNovember 1, 2024 | finanznachrichten.deTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positioned at the absolute center of this incoming capital flood— a project so fundamentally essential to the crypto ecosystem that institutional investors simply cannot ignore it.September 3 at 2:00 AM | Crypto 101 Media (Ad)VanEck Bionic Engineering UCITS ETF (CYBO.L)May 17, 2024 | au.finance.yahoo.comVaneck Sustainable World Ew Ucits Etf Share ChatNovember 20, 2023 | lse.co.ukVanEck Global Mining UCITS A (GIGB)July 14, 2023 | uk.investing.comVanEck Genomics and Healthcare Innovators UCITS ETF (CURE)June 3, 2023 | uk.investing.comGDX VanEck Gold Miners ETFMay 20, 2023 | seekingalpha.comSee More Headlines CYBG Stock Analysis - Frequently Asked Questions How have CYBG shares performed this year? VanEck Bionic Engineering UCITS ETF A Acc's stock was trading at GBX 16.50 at the beginning of the year. Since then, CYBG stock has decreased by 6.0% and is now trading at GBX 15.51. How do I buy shares of VanEck Bionic Engineering UCITS ETF A Acc? Shares of CYBG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of VanEck Bionic Engineering UCITS ETF A Acc own? Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Bionic Engineering UCITS ETF A Acc investors own include National Australia Bank (NAB), Virgin Money UK (VMUK), G-III Apparel Group (GIII), Alphabet (GOOG), Ionis Pharmaceuticals (IONS), Svenska Handelsbanken Ab Publ (SVNLY) and Western Union (WU). Industry, Sector and Symbol Stock ExchangeLON SectorFinance Industry Banks - Regional - Europe Sub-IndustryN/A Current SymbolLON:CYBG CIKN/A Webwww.cybg.com Phone+44-141-2324763FaxN/AEmployees5,762Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E Ratio0.01 P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales£1.24 billion Price / Sales0.18 Cash FlowGBX 116.01 per share Price / Cash Flow0.13 Book ValueGBX 355.10 per share Price / Book0.04Miscellaneous Outstanding Shares1,434,489,984Free FloatN/AMarket Cap£222.50 million OptionableNot Optionable BetaN/A 10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (LON:CYBG) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Bionic Engineering UCITS ETF A Acc Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Bionic Engineering UCITS ETF A Acc With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.